Key statistics
On Friday, Enovis Corp (C520:DUS) closed at 39.00, 7.14% above its 52-week low of 36.40, set on Aug 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 39.80 |
---|---|
High | 39.80 |
Low | 39.00 |
Bid | 38.80 |
Offer | 39.40 |
Previous close | 40.40 |
Average volume | 54.40 |
---|---|
Shares outstanding | 55.85m |
Free float | 55.32m |
P/E (TTM) | -- |
Market cap | 2.44bn USD |
EPS (TTM) | -1.96 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 18:31 BST.
More ▼
Announcements
- Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
- Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
- Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
- Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
- Enovis to Participate in Upcoming Investor Conferences
- Enovis Announces Second Quarter 2024 Results
- Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
- Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
- Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
- Enovis Announces First Quarter 2024 Results
More ▼